What do systematic reviews say?

Dopamine antagonists vs placebo

It is very uncertain whether dopamine antagonists changes nausea ‐ intraoperative compared with placebo (very low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.38 [0.27, 0.52]
  15 studies · 1180 participants
  Very low
• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.61 [0.48, 0.79]
  7 studies · 601 participants
  Low

Dopamine antagonists vs placebo

Dopamine antagonists may leads to lower vomiting ‐ intraoperative compared with placebo (low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.41 [0.28, 0.6]
  12 studies · 942 participants
  Low

Dopamine antagonists vs placebo

It is very uncertain whether dopamine antagonists changes vomiting ‐ postoperative compared with placebo (very low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.63 [0.44, 0.92]
  9 studies · 860 participants
  Very low

Bromocriptine vs no treatment

Bromocriptine may leads to lower miscarriages compared with no treatment (low certainty).

• Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent… 2016 · Cochrane Headline outcomes only
  RR 0.28 [0.09, 0.87]
  1 study · 46 participants
  Low

Bromocriptine vs no treatment

It is very uncertain whether bromocriptine changes live births compared with no treatment (very low certainty).

• Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent… 2016 · Cochrane Headline outcomes only
  RR 1.5 [0.93, 2.42]
  1 study · 46 participants
  Very low

Bromocriptine vs no treatment

It is very uncertain whether bromocriptine changes conception compared with no treatment (very low certainty).

• Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent… 2016 · Cochrane Headline outcomes only
  RR 0.92 [0.77, 1.09]
  1 study · 46 participants
  Very low

Bromocriptine vs no treatment

• Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Bromocriptine vs no treatment

• Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Bromocriptine vs no treatment

• Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Bromocriptine vs no treatment

• Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported